Pulmonary Hypertension: A Complication of Haemolytic States

Practical Management of Haemoglobinopathies

Volumn , Issue , 2007, Pages 130-133

  Okpala, Iheanyi E ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Exchange blood transfusion (EBT); L carnitine therapy; Paroxysmal nocturnal haemoglobinuria (PNH); Pulmonary hypertension; Pulmonary hypertension (PHT)

Indexed keywords

EID: 26444610425     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988398.ch14     Document Type: Chapter

References (12)

1. Reiter CD, Wang X, Tanus-Santos JE et al. Cell- free hemoglobin limits nitric oxide bioavailability in sickle cell disease. Nature Med 11 Nov 2002; Online.
2. Powars D, Weidman JA, Odom-Maryon T et al. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 1988; 67: 66-76.
3. Samuels MP, Stebbens VA, Davies SC et al. Sleep related upper airway obstruction and hypoxaemia in sickle cell disease. Arch Dis Child 1992; 67: 925-9.
4. Yung GL, Channick RN, Fedullo PF et al. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit CareMed 1998; 157: 1690-3.
5. Ataga KI, Kelly EA, Santucci S et al. Prevalence of pulmonary hypertension in sickle cell disease. Blood 2002; 100 (Suppl): 451a.
6. Castro O. Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am 1996; 10: 1289-303.
7. Gladwin MT, Castro O, Jison M et al. A prospective clinical study of the prevalence and etiology of secondary pulmonary hypertension in sickle cell anemia. Abstract Book of the National Sickle Cell Conference of USA, Washington, DC, 17-23 September, 2002, p. 55.
8. Johnson CS, Giorgio AJ. Arterial blood pressure in adults with sickle cell disease. Arch Intern Med 1981; 141: 891-3.
9. Hammond TG, Mosesson MW. Fat small bowel necrosis and pulmonary hypertension in sickle cell disease. Arch Intern Med 1989; 149: 447-8.
10. Coles W, Nicolas JS, Smatlak PK et al. A clinical study of the efficacy of nitric oxide delivery via portable versus conventional systems to reduce secondary pulmonary hypertension in sickle cell anemia. Abstract Book of the National Sickle Cell Conference of USA, Washington, DC, 17-23 September, 2002, p. 54.
11. Morris CR, Hagar W, Vam Warmerdam J et al. Arginine therapy improves pulmonary artery pressures in patients with sickle cell disease and pulmonary hypertension. Blood 2002; 100 (Suppl): 452a.
12. El-Beshlawy A, Abdelaouff E, Hassan F, Bebawy I. Pulmonary hypertension in sickle cell disease. Abstract Book of the 25 th Meeting of the International Society of Haematology (African & European Division), Durban, South Africa, 18-23 September, 1999, p. 120.